| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.3 |